ICENTICAFTOR |
ICENTICAFTOR : Potentiator of CFTR
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CFTR (Mutant:F508del, G551D, WT) |
|
Potentiator
up to 1 uM
Selectivity
Potency Cellular
In Vitro
CFTR
(Mutant:F508del, G551D, WT)
Mode of Action: Potentiator
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.1c00343
In Vivo Validations
Rat
Dose: 1 mg/Kg IV, 3 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
10.2 h MRT
Systemic clearance:
5 mL/min/kg
Cmax:
1364 nM
Area Under the Curve::
20635 nM/h/L
Fb :
90.3%
Bioavailability:
90% PO
Volume of Distribution at Steady-State:
3.0 L/Kg
DOI Reference: 10.1021/acs.jmedchem.1c00343
Dog
Dose: 0.46 mg/kg IV, 3 mg/kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
4.4 h MRT
Systemic clearance:
29 mL/min/Kg
Cmax:
1952 nM PO
Area Under the Curve::
8670 nmol/h/L
Fb :
94.8%
Bioavailability:
146% PO
Volume of Distribution at Steady-State:
7.5 L/Kh
DOI Reference: 10.1021/acs.jmedchem.1c00343
Monkey (Cynomolgus)
Dose: 0.1 mg/Kg IV, 10 mg/Kg PO
Route of delivery:
Intravenous, Oral
Plasma half life:
3.3 h MRT
Systemic clearance:
18 mL/min/kg
Cmax:
2303 nM PO
Area Under the Curve::
6780 nmol/h/L
Fb :
88.0%
Bioavailability:
26% PO
Volume of Distribution at Steady-State:
3.5 L/Kg
DOI Reference: 10.1021/acs.jmedchem.1c00343
Chemical Information
| Molecular Formula | C12H13F6N3O3 |
| SMILEs | COc1nc(C(=O)NC[C@](C)(O)C(F)(F)F)c(N)cc1C(F)(F)F |
| InChI | InChI=1S/C12H13F6N3O3/c1-10(23,12(16,17)18)4-20-8(22)7-6(19)3-5(11(13,14)15)9(21-7)24-2/h3,23H,4,19H2,1-2H3,(H,20,22)/t10-/m0/s1 |
| Molecular weight | 361.09 Da |
| AlogP | 1.7343 |
| HBond acceptors | 6 |
| HBond donors | 4 |
| Atoms | 37 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.